CNTN
Tharimmune, Inc.
NASDAQ · USHealthcareBiotechnology
$2.05-10.87%
Price as of Jul 20, 2026
CNTN analysis
Tharimmune, Inc. stock analysis
Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.
Analysis for CNTN is not published yet
Browse the public research library while company-specific analysis is being prepared. Explore research